Skip to main content
Top
Published in: Urolithiasis 4/2012

01-08-2012 | Original Paper

Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine

Authors: Hans-Göran Tiselius, Renato Ribeiro Nogueira Ferraz, Ita Pfeferman Heilberg

Published in: Urolithiasis | Issue 4/2012

Login to get access

Abstract

This study aimed at formulating simplified estimates of ion-activity products of calcium oxalate (APCaOx) and calcium phosphate (APCaP) in mouse urineto find the most important determinants in order to limit the analytical work-up. Literature data on mouse urine composition was used to determine the relative effect of each urine variable on the two ion-activity products. APCaOx and APCaP were calculated by iterative approximation with the EQUIL2 computerized program. The most important determinants for APCaOx were calcium, oxalate and citrate and for APCaP calcium, phosphate, citrate, magnesium and pH. Urine concentrations of the variables were used. A simplified estimate of APCaOx (AP(CaOx)-indexMOUSE) that numerically approximately corresponded to 108 × APCaOx was given the following expression:
$$ {\text{AP(CaOx)-index}}_{\text{MOUSE}} = 0.70 \times {\text{Calcium}}^{1.05} \times {\text{Oxalate}}^{0.95} (0.90 - 0.0225 \times {\text{Citrate}}) + (6.6 \times 10^{ - 8} \times {\text{Citrate}}^{3.98} ) $$
For a series of urine samples with various composition the coefficient of correlation between AP(CaOx)-indexMOUSE and 108 × APCaOx was 0.99 (p = 0.00000). A similar estimate of APCaP (AP(CaP)-indexMOUSE) was formulated so that it approximately would correspond numerically to 1014 × APCaP taking the following form:
$$ {\text{AP(CaP)-index}}_{\text{MOUSE}} = \frac{{0.05 \times {\text{Calcium}}^{1.17} \times {\text{Phosphate}}^{0.85} \times {\text{Magnesium}}^{0.18}\times ({\text{pH}} - 4.5)^{6.8} }}{{{\text{Citrate}}^{0.76} }} $$
For a series of variations in urine composition the coefficient of correlation was 0.95 (p = 0.00000). The two approximate estimates shown in this article are simplified expressions of APCaOx and APCaP. The intention of these theoretical calculations was not to get methods for accurate information on the saturation levels in urine, but to have mathematical tools useful for rough conclusions on the outcome of different experimental situations in mice. It needs to be emphasized that the accuracy will be negatively influenced if urine variables not included in the formulas differ very much from basic concentrations.
Literature
1.
go back to reference Tiselius HG (1984) A simplified estimate of the ion-activity product of calcium phosphate in urine. Eur Urol 10:191–194PubMed Tiselius HG (1984) A simplified estimate of the ion-activity product of calcium phosphate in urine. Eur Urol 10:191–194PubMed
2.
go back to reference Robertson WG (1969) Measurement of ionized calcium in biological fluids. Clin Chim Acta 24:149–157PubMedCrossRef Robertson WG (1969) Measurement of ionized calcium in biological fluids. Clin Chim Acta 24:149–157PubMedCrossRef
3.
go back to reference Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL2: a basic computer program for calculation of urinary saturation. J Urol 134:1242–1244PubMed Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL2: a basic computer program for calculation of urinary saturation. J Urol 134:1242–1244PubMed
4.
go back to reference Ashby R, Györy AZ (1997) Thermodynamic equilibrium model for calcium salt urolithiasis: clinical application. Exp Nephrol 5:246–252PubMed Ashby R, Györy AZ (1997) Thermodynamic equilibrium model for calcium salt urolithiasis: clinical application. Exp Nephrol 5:246–252PubMed
5.
go back to reference Rodgers AL, Allie-Hamdulay S, Jackson G, Tiselius HG (2011) Simulating calcium salt precipitation in the nephron using chemical speciation. Urol Res e-publication 39:245–251 Rodgers AL, Allie-Hamdulay S, Jackson G, Tiselius HG (2011) Simulating calcium salt precipitation in the nephron using chemical speciation. Urol Res e-publication 39:245–251
6.
go back to reference Tiselius H-G (1982) An improved method for then routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 122:409–418PubMedCrossRef Tiselius H-G (1982) An improved method for then routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 122:409–418PubMedCrossRef
7.
go back to reference Tiselius H-G (1989) Standardized estimate of the ion-activity product of calcium oxalate in from renal stone formers. Eur Urol 16:48–50PubMed Tiselius H-G (1989) Standardized estimate of the ion-activity product of calcium oxalate in from renal stone formers. Eur Urol 16:48–50PubMed
8.
go back to reference Tiselius H-G (1991) Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47:255–259PubMedCrossRef Tiselius H-G (1991) Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47:255–259PubMedCrossRef
9.
go back to reference Tiselius H-G, Ferraz RR, Heilberg IP (2003) An approximate estimate of the ion-activity product of calcium oxalate in rat urine. Urol Res 31:410–413PubMedCrossRef Tiselius H-G, Ferraz RR, Heilberg IP (2003) An approximate estimate of the ion-activity product of calcium oxalate in rat urine. Urol Res 31:410–413PubMedCrossRef
10.
go back to reference Khan SR, Glenton PA (2008) Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted typ IIa sodium-phosphate cotransporter. Am J Physiol Renal Physiol 294:F1109–F1115PubMedCrossRef Khan SR, Glenton PA (2008) Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted typ IIa sodium-phosphate cotransporter. Am J Physiol Renal Physiol 294:F1109–F1115PubMedCrossRef
11.
go back to reference Khan SR, Glenton PA (2010) Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 184:1189–1196PubMedCrossRef Khan SR, Glenton PA (2010) Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 184:1189–1196PubMedCrossRef
12.
go back to reference Salido EC, Xiao ML, Yang L, Xia W, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdry J (2006) Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. PNAS 103:18249–18254PubMedCrossRef Salido EC, Xiao ML, Yang L, Xia W, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdry J (2006) Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer. PNAS 103:18249–18254PubMedCrossRef
13.
go back to reference Grujic D, Salido EC, Shenoy BC, Langman CB, McGrath ME, Patel RJ, Rashid A, Mandpati S, Jung CW, Margolin AL (2009) Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degradingt enzyme in mice with hyperoxaluria. Am J Nephrol 29:86–93PubMedCrossRef Grujic D, Salido EC, Shenoy BC, Langman CB, McGrath ME, Patel RJ, Rashid A, Mandpati S, Jung CW, Margolin AL (2009) Hyperoxaluria is reduced and nephrocalcinosis prevented with an oxalate-degradingt enzyme in mice with hyperoxaluria. Am J Nephrol 29:86–93PubMedCrossRef
Metadata
Title
Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine
Authors
Hans-Göran Tiselius
Renato Ribeiro Nogueira Ferraz
Ita Pfeferman Heilberg
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 4/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0443-1

Other articles of this Issue 4/2012

Urolithiasis 4/2012 Go to the issue